SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '1n1a'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1BKF_A_FK5A108_1 (FK506 BINDING PROTEIN)	1n1a	FKBP52 (Homo sapiens)	8 / 9	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 PHE A 130	None	0.65A	1bkfA-1n1aA: 17.7	1bkfA-1n1aA: 44.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1C9H_A_RAPA108_1 (FKBP12.6)	1n1a	FKBP52 (Homo sapiens)	9 / 12	TYR A 57 ASP A 68 PHE A 77 GLU A 85 VAL A 86 ILE A 87 TYR A 113 ILE A 122 PHE A 130	None	0.75A	1c9hA-1n1aA: 17.6	1c9hA-1n1aA: 38.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1FAP_A_RAPA108_1 (FK506-BINDING PROTEIN)	1n1a	FKBP52 (Homo sapiens)	10 / 12	TYR A 57 ASP A 68 PHE A 77 GLU A 85 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.68A	1fapA-1n1aA: 18.2	1fapA-1n1aA: 45.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1FAP_A_RAPA108_1 (FK506-BINDING PROTEIN)	1n1a	FKBP52 (Homo sapiens)	7 / 12	TYR A 57 ASP A 68 PHE A 77 GLU A 85 VAL A 86 TRP A 90 ILE A 122	None	1.11A	1fapA-1n1aA: 18.2	1fapA-1n1aA: 45.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1FKB_A_RAPA108_1 (FK506 BINDING PROTEIN)	1n1a	FKBP52 (Homo sapiens)	9 / 12	TYR A 57 ASP A 68 PHE A 77 GLU A 85 VAL A 86 ILE A 87 TRP A 90 TYR A 113 PHE A 130	None	0.74A	1fkbA-1n1aA: 18.2	1fkbA-1n1aA: 45.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1FKB_A_RAPA108_1 (FK506 BINDING PROTEIN)	1n1a	FKBP52 (Homo sapiens)	7 / 12	TYR A 57 ASP A 68 PHE A 77 GLU A 85 VAL A 86 TRP A 90 ILE A 122	None	1.14A	1fkbA-1n1aA: 18.2	1fkbA-1n1aA: 45.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1FKF_A_FK5A108_1 (FK506 BINDING PROTEIN)	1n1a	FKBP52 (Homo sapiens)	9 / 11	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.54A	1fkfA-1n1aA: 17.7	1fkfA-1n1aA: 45.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1FKJ_A_FK5A108_1 (FK506 BINDING PROTEIN)	1n1a	FKBP52 (Homo sapiens)	9 / 11	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.54A	1fkjA-1n1aA: 17.7	1fkjA-1n1aA: 45.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1FKL_A_RAPA108_1 (FK506 BINDING PROTEIN)	1n1a	FKBP52 (Homo sapiens)	10 / 12	TYR A 57 ASP A 68 PHE A 77 GLU A 85 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.72A	1fklA-1n1aA: 18.2	1fklA-1n1aA: 45.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1FKL_A_RAPA108_1 (FK506 BINDING PROTEIN)	1n1a	FKBP52 (Homo sapiens)	6 / 12	TYR A 57 ASP A 68 PHE A 77 GLU A 85 VAL A 86 ILE A 122	None	1.00A	1fklA-1n1aA: 18.2	1fklA-1n1aA: 45.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1PBK_A_RAPA225_1 (FKBP25)	1n1a	FKBP52 (Homo sapiens)	9 / 12	TYR A 57 ASP A 68 GLY A 84 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.57A	1pbkA-1n1aA: 17.9	1pbkA-1n1aA: 39.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1Q6I_A_FK5A301_1 (FKBP-TYPE PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKPA)	1n1a	FKBP52 (Homo sapiens)	8 / 9	TYR A 57 ASP A 68 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.65A	1q6iA-1n1aA: 15.9	1q6iA-1n1aA: 29.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1Q6I_B_FK5B401_1 (FKBP-TYPE PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKPA)	1n1a	FKBP52 (Homo sapiens)	8 / 10	TYR A 57 ASP A 68 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.57A	1q6iB-1n1aA: 15.7	1q6iB-1n1aA: 29.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1R5L_A_VIVA301_0 (PROTEIN (ALPHA-TOCOPHEROL TRANSFER PROTEIN))	1n1a	FKBP52 (Homo sapiens)	5 / 12	ILE A 122 ILE A 25 ILE A 105 VAL A 129 ILE A 87	None	1.18A	1r5lA-1n1aA: undetectable	1r5lA-1n1aA: 22.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1TCO_C_FK5C509_2 (FK506-BINDING PROTEIN)	1n1a	FKBP52 (Homo sapiens)	9 / 11	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.63A	1tcoC-1n1aA: 17.8	1tcoC-1n1aA: 45.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1YAT_A_FK5A108_1 (FK506 BINDING PROTEIN)	1n1a	FKBP52 (Homo sapiens)	9 / 11	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.54A	1yatA-1n1aA: 19.7	1yatA-1n1aA: 39.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2DG3_A_RAPA501_1 (FK506-BINDING PROTEIN 1A)	1n1a	FKBP52 (Homo sapiens)	9 / 11	TYR A 57 ASP A 68 PHE A 77 GLU A 85 VAL A 86 ILE A 87 TRP A 90 TYR A 113 PHE A 130	None	0.76A	2dg3A-1n1aA: 18.0	2dg3A-1n1aA: 45.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2DG3_A_RAPA501_1 (FK506-BINDING PROTEIN 1A)	1n1a	FKBP52 (Homo sapiens)	6 / 11	TYR A 57 ASP A 68 PHE A 77 GLU A 85 VAL A 86 ILE A 122	None	1.15A	2dg3A-1n1aA: 18.0	2dg3A-1n1aA: 45.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2DG4_A_RAPA501_1 (FK506-BINDING PROTEIN 1A)	1n1a	FKBP52 (Homo sapiens)	8 / 11	TYR A 57 ASP A 68 PHE A 77 GLU A 85 VAL A 86 ILE A 87 TYR A 113 PHE A 130	None	0.82A	2dg4A-1n1aA: 17.6	2dg4A-1n1aA: 44.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2DG4_A_RAPA501_1 (FK506-BINDING PROTEIN 1A)	1n1a	FKBP52 (Homo sapiens)	6 / 11	TYR A 57 ASP A 68 PHE A 77 GLU A 85 VAL A 86 ILE A 122	None	1.05A	2dg4A-1n1aA: 17.6	2dg4A-1n1aA: 44.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2DG9_A_RAPA501_1 (FK506-BINDING PROTEIN 1A)	1n1a	FKBP52 (Homo sapiens)	7 / 11	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 87 TYR A 113 PHE A 130	None	0.65A	2dg9A-1n1aA: 17.8	2dg9A-1n1aA: 44.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2DG9_A_RAPA501_1 (FK506-BINDING PROTEIN 1A)	1n1a	FKBP52 (Homo sapiens)	5 / 11	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 122	None	1.03A	2dg9A-1n1aA: 17.8	2dg9A-1n1aA: 44.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2FKE_A_FK5A108_1 (FK506 BINDING PROTEIN)	1n1a	FKBP52 (Homo sapiens)	9 / 11	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.54A	2fkeA-1n1aA: 17.8	2fkeA-1n1aA: 45.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2VCD_A_RAPA138_1 (OUTER MEMBRANE PROTEIN MIP)	1n1a	FKBP52 (Homo sapiens)	7 / 11	TYR A 57 PHE A 67 ASP A 68 VAL A 86 ILE A 87 TRP A 90 TYR A 113	None	0.83A	2vcdA-1n1aA: 14.3	2vcdA-1n1aA: 33.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2VN1_A_FK5A501_1 (70 KDA PEPTIDYLPROLYL ISOMERASE)	1n1a	FKBP52 (Homo sapiens)	9 / 11	TYR A 57 PHE A 67 ASP A 68 PHE A 77 VAL A 86 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.62A	2vn1A-1n1aA: 20.8	2vn1A-1n1aA: 39.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2VN1_B_FK5B501_1 (70 KDA PEPTIDYLPROLYL ISOMERASE)	1n1a	FKBP52 (Homo sapiens)	8 / 10	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 PHE A 130	None	0.67A	2vn1B-1n1aA: 20.8	2vn1B-1n1aA: 39.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3D4S_A_TIMA401_2 (BETA-2 ADRENERGIC RECEPTOR/T4-LYSOZYME CHIMERA)	1n1a	FKBP52 (Homo sapiens)	3 / 3	THR A 58 SER A 69 PHE A 135	None	0.70A	3d4sA-1n1aA: undetectable	3d4sA-1n1aA: 14.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3E4E_A_4PZA501_1 (CYTOCHROME P450 2E1)	1n1a	FKBP52 (Homo sapiens)	3 / 3	ALA A 93 THR A 96 CYH A 103	None	0.75A	3e4eA-1n1aA: undetectable	3e4eA-1n1aA: 15.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3IHZ_A_FK5A501_1 (70 KDA PEPTIDYLPROLYL ISOMERASE, PUTATIVE)	1n1a	FKBP52 (Homo sapiens)	9 / 10	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.53A	3ihzA-1n1aA: 20.9	3ihzA-1n1aA: 39.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3IHZ_A_FK5A501_2 (70 KDA PEPTIDYLPROLYL ISOMERASE, PUTATIVE)	1n1a	FKBP52 (Homo sapiens)	6 / 8	TYR A 57 ASP A 68 PHE A 77 TRP A 90 TYR A 113 ILE A 122	None	0.48A	3ihzB-1n1aA: 21.1	3ihzB-1n1aA: 39.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3KZ7_A_RAPA225_1 (FK506-BINDING PROTEIN 3)	1n1a	FKBP52 (Homo sapiens)	8 / 10	TYR A 57 ASP A 68 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.60A	3kz7A-1n1aA: 18.1	3kz7A-1n1aA: 45.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3O5R_A_FK5A1001_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5)	1n1a	FKBP52 (Homo sapiens)	10 / 11	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 LYS A 121 ILE A 122 PHE A 130	None	0.68A	3o5rA-1n1aA: 21.5	3o5rA-1n1aA: 65.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3UF8_A_FK5A114_1 (UBIQUITIN-LIKE PROTEIN SMT3, PEPTIDYL-PROLYL CIS-TRANS ISOMERASE)	1n1a	FKBP52 (Homo sapiens)	9 / 10	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.57A	3uf8A-1n1aA: 19.0	3uf8A-1n1aA: 35.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3UQA_A_FK5A114_1 (UBIQUITIN-LIKE PROTEIN SMT3, PEPTIDYL-PROLYL CIS-TRANS ISOMERASE)	1n1a	FKBP52 (Homo sapiens)	9 / 10	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.59A	3uqaA-1n1aA: 18.8	3uqaA-1n1aA: 35.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3UQB_A_FK5A114_1 (UBIQUITIN-LIKE PROTEIN SMT3, PEPTIDYL-PROLYL CIS-TRANS ISOMERASE)	1n1a	FKBP52 (Homo sapiens)	8 / 8	TYR A 57 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.54A	3uqbA-1n1aA: 19.1	3uqbA-1n1aA: 34.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3VAW_A_FK5A114_1 (UBIQUITIN-LIKE PROTEIN SMT3,PEPTIDYL-PROLYL CIS-TRANS ISOMERASE)	1n1a	FKBP52 (Homo sapiens)	9 / 11	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.58A	3vawA-1n1aA: 18.4	3vawA-1n1aA: 35.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DRH_A_RAPA201_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5)	1n1a	FKBP52 (Homo sapiens)	9 / 12	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.68A	4drhA-1n1aA: 20.7	4drhA-1n1aA: 61.43
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DRH_A_RAPA201_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5)	1n1a	FKBP52 (Homo sapiens)	5 / 12	TYR A 57 ASP A 68 TYR A 113 LYS A 121 ILE A 122	None	0.87A	4drhA-1n1aA: 20.7	4drhA-1n1aA: 61.43
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DRH_D_RAPD201_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5)	1n1a	FKBP52 (Homo sapiens)	9 / 12	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.64A	4drhD-1n1aA: 20.8	4drhD-1n1aA: 61.43
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DRI_A_RAPA201_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5)	1n1a	FKBP52 (Homo sapiens)	9 / 11	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.56A	4driA-1n1aA: 22.5	4driA-1n1aA: 61.43
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DRJ_A_RAPA201_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP4)	1n1a	FKBP52 (Homo sapiens)	10 / 11	TYR A 57 ASP A 68 PHE A 77 GLU A 85 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.59A	4drjA-1n1aA: 22.6	4drjA-1n1aA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DZ2_A_FK5A200_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE)	1n1a	FKBP52 (Homo sapiens)	9 / 11	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.56A	4dz2A-1n1aA: 18.8 4dz2B-1n1aA: 18.9	4dz2A-1n1aA: 47.45 4dz2B-1n1aA: 47.45
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DZ2_B_FK5B200_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE)	1n1a	FKBP52 (Homo sapiens)	9 / 11	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.55A	4dz2A-1n1aA: 18.8 4dz2B-1n1aA: 18.9	4dz2A-1n1aA: 47.45 4dz2B-1n1aA: 47.45
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DZ3_A_FK5A201_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE)	1n1a	FKBP52 (Homo sapiens)	9 / 10	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.55A	4dz3A-1n1aA: 18.9	4dz3A-1n1aA: 47.45
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DZ3_B_FK5B201_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE)	1n1a	FKBP52 (Homo sapiens)	9 / 10	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.57A	4dz3B-1n1aA: 13.6	4dz3B-1n1aA: 47.45
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4LAX_A_FK5A301_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP4)	1n1a	FKBP52 (Homo sapiens)	10 / 10	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 LYS A 121 ILE A 122 PHE A 130	None	0.58A	4laxA-1n1aA: 22.1	4laxA-1n1aA: 86.58
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4NNR_A_FK5A201_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP2)	1n1a	FKBP52 (Homo sapiens)	6 / 12	ASP A 68 PHE A 77 TRP A 90 TYR A 113 LYS A 121 ILE A 122	None	0.76A	4nnrA-1n1aA: 15.0 4nnrB-1n1aA: 15.0	4nnrA-1n1aA: 41.67 4nnrB-1n1aA: 41.67
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4NNR_A_FK5A201_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP2)	1n1a	FKBP52 (Homo sapiens)	9 / 12	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.56A	4nnrA-1n1aA: 15.0 4nnrB-1n1aA: 15.0	4nnrA-1n1aA: 41.67 4nnrB-1n1aA: 41.67
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4NNR_B_FK5B201_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP2)	1n1a	FKBP52 (Homo sapiens)	10 / 10	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 LYS A 121 ILE A 122 PHE A 130	None	0.70A	4nnrB-1n1aA: 15.0	4nnrB-1n1aA: 41.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ODO_A_FK5A205_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE SLYD)	1n1a	FKBP52 (Homo sapiens)	5 / 10	TYR A 57 ASP A 68 ILE A 87 TYR A 113 PHE A 130	None	0.68A	4odoA-1n1aA: 11.4	4odoA-1n1aA: 18.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ODO_B_FK5B203_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE SLYD)	1n1a	FKBP52 (Homo sapiens)	5 / 10	TYR A 57 ASP A 68 ILE A 87 TYR A 113 PHE A 130	None	0.65A	4odoB-1n1aA: 11.1	4odoB-1n1aA: 18.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ODO_C_FK5C204_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE SLYD)	1n1a	FKBP52 (Homo sapiens)	5 / 10	TYR A 57 ASP A 68 ILE A 87 TYR A 113 PHE A 130	None	0.67A	4odoC-1n1aA: 11.0	4odoC-1n1aA: 18.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ODR_A_FK5A201_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE SLYD, PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP1A CHIMERA)	1n1a	FKBP52 (Homo sapiens)	6 / 12	TYR A 57 ASP A 68 ILE A 87 TYR A 113 ILE A 122 PHE A 130	None	0.61A	4odrA-1n1aA: 12.9 4odrB-1n1aA: 13.0	4odrA-1n1aA: 25.17 4odrB-1n1aA: 25.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ODR_B_FK5B201_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE SLYD, PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP1A CHIMERA)	1n1a	FKBP52 (Homo sapiens)	5 / 11	TYR A 57 ASP A 68 ILE A 87 TYR A 113 PHE A 130	None	0.66A	4odrA-1n1aA: 12.9 4odrB-1n1aA: 13.0	4odrA-1n1aA: 25.17 4odrB-1n1aA: 25.17
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4QT2_A_RAPA202_1 (FK506-BINDING PROTEIN (FKBP)-TYPE PEPTIDYL-PROPYL ISOMERASE)	1n1a	FKBP52 (Homo sapiens)	10 / 10	TYR A 57 ASP A 68 PHE A 77 GLU A 85 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.69A	4qt2A-1n1aA: 20.9	4qt2A-1n1aA: 36.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4QT3_A_RAPA202_1 (FK506-BINDING PROTEIN (FKBP)-TYPE PEPTIDYL-PROPYL ISOMERASE)	1n1a	FKBP52 (Homo sapiens)	10 / 10	TYR A 57 ASP A 68 PHE A 77 GLU A 85 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.70A	4qt3A-1n1aA: 20.3	4qt3A-1n1aA: 38.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5B8I_C_FK5C201_3 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE)	1n1a	FKBP52 (Homo sapiens)	9 / 12	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.63A	5b8iC-1n1aA: 17.5	5b8iC-1n1aA: 37.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5D75_A_FK5A301_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP3)	1n1a	FKBP52 (Homo sapiens)	8 / 11	TYR A 57 ASP A 68 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.53A	5d75A-1n1aA: 18.7	5d75A-1n1aA: 39.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ESL_A_1YNA701_2 (LANOSTEROL 14-ALPHA DEMETHYLASE)	1n1a	FKBP52 (Homo sapiens)	4 / 5	ALA A 116 PRO A 109 GLY A 22 LEU A 62	None	0.98A	5eslA-1n1aA: undetectable	5eslA-1n1aA: 12.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5GPG_A_RAPA301_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP3)	1n1a	FKBP52 (Homo sapiens)	8 / 11	TYR A 57 ASP A 68 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.59A	5gpgA-1n1aA: 18.6	5gpgA-1n1aA: 47.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5HKG_A_RAPA201_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP1B)	1n1a	FKBP52 (Homo sapiens)	9 / 12	TYR A 57 ASP A 68 PHE A 77 GLU A 85 VAL A 86 ILE A 87 TYR A 113 ILE A 122 PHE A 130	None	0.76A	5hkgA-1n1aA: 17.7	5hkgA-1n1aA: 38.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5HUA_A_FK5A201_1 (FK506-BINDING PROTEIN 1)	1n1a	FKBP52 (Homo sapiens)	8 / 11	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 PHE A 130	None	0.52A	5huaA-1n1aA: 20.0	5huaA-1n1aA: 41.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5HW8_A_FK5A201_1 (FK506-BINDING PROTEIN 1)	1n1a	FKBP52 (Homo sapiens)	8 / 11	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122	None	0.65A	5hw8A-1n1aA: 16.5 5hw8D-1n1aA: 16.7	5hw8A-1n1aA: 36.49 5hw8D-1n1aA: 36.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5HW8_B_FK5B201_1 (FK506-BINDING PROTEIN 1)	1n1a	FKBP52 (Homo sapiens)	5 / 11	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 122	None	1.22A	5hw8B-1n1aA: 16.5	5hw8B-1n1aA: 36.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5HW8_B_FK5B201_1 (FK506-BINDING PROTEIN 1)	1n1a	FKBP52 (Homo sapiens)	8 / 11	TYR A 57 ASP A 68 PHE A 77 VAL A 86 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.52A	5hw8B-1n1aA: 16.5	5hw8B-1n1aA: 36.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5HW8_C_FK5C201_1 (FK506-BINDING PROTEIN 1)	1n1a	FKBP52 (Homo sapiens)	8 / 10	TYR A 57 ASP A 68 VAL A 86 ILE A 87 TRP A 90 TYR A 113 LEU A 128 PHE A 130	None	0.59A	5hw8C-1n1aA: 16.4 5hw8H-1n1aA: 13.5	5hw8C-1n1aA: 36.49 5hw8H-1n1aA: 36.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5HW8_D_FK5D201_1 (FK506-BINDING PROTEIN 1)	1n1a	FKBP52 (Homo sapiens)	9 / 11	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.59A	5hw8D-1n1aA: 16.7	5hw8D-1n1aA: 36.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5HW8_E_FK5E201_1 (FK506-BINDING PROTEIN 1)	1n1a	FKBP52 (Homo sapiens)	8 / 11	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 PHE A 130	None	0.69A	5hw8E-1n1aA: 16.6	5hw8E-1n1aA: 36.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5HW8_F_FK5F201_1 (FK506-BINDING PROTEIN 1)	1n1a	FKBP52 (Homo sapiens)	8 / 12	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 PHE A 130	None	0.61A	5hw8B-1n1aA: 16.5 5hw8F-1n1aA: 13.5 5hw8G-1n1aA: 16.6	5hw8B-1n1aA: 36.49 5hw8F-1n1aA: 36.49 5hw8G-1n1aA: 36.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5HW8_G_FK5G201_2 (FK506-BINDING PROTEIN 1)	1n1a	FKBP52 (Homo sapiens)	9 / 11	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.62A	5hw8G-1n1aA: 16.6	5hw8G-1n1aA: 36.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5HW8_H_FK5H201_1 (FK506-BINDING PROTEIN 1)	1n1a	FKBP52 (Homo sapiens)	5 / 8	ASP A 68 PHE A 77 VAL A 86 ILE A 87 TRP A 90	None	0.55A	5hw8H-1n1aA: 13.5	5hw8H-1n1aA: 36.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5HW8_H_FK5H201_1 (FK506-BINDING PROTEIN 1)	1n1a	FKBP52 (Homo sapiens)	6 / 8	TYR A 57 ASP A 68 PHE A 77 VAL A 86 TRP A 90 PHE A 130	None	0.59A	5hw8H-1n1aA: 13.5	5hw8H-1n1aA: 36.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5HWC_A_FK5A201_1 (FK506-BINDING PROTEIN 1A)	1n1a	FKBP52 (Homo sapiens)	9 / 11	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.52A	5hwcA-1n1aA: 18.1	5hwcA-1n1aA: 42.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6MKE_A_FK5A201_0 (PEPTIDYLPROLYL ISOMERASE)	1n1a	FKBP52 (Homo sapiens)	9 / 12	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.56A	6mkeA-1n1aA: 20.8 6mkeD-1n1aA: 20.7	6mkeA-1n1aA: 43.96 6mkeD-1n1aA: 43.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6MKE_B_FK5B201_0 (PEPTIDYLPROLYL ISOMERASE)	1n1a	FKBP52 (Homo sapiens)	9 / 12	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.52A	6mkeB-1n1aA: 20.8 6mkeC-1n1aA: 20.7	6mkeB-1n1aA: 43.96 6mkeC-1n1aA: 43.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6MKE_C_FK5C201_1 (PEPTIDYLPROLYL ISOMERASE)	1n1a	FKBP52 (Homo sapiens)	9 / 10	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.59A	6mkeC-1n1aA: 20.7	6mkeC-1n1aA: 43.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6MKE_D_FK5D201_1 (PEPTIDYLPROLYL ISOMERASE)	1n1a	FKBP52 (Homo sapiens)	9 / 10	TYR A 57 ASP A 68 PHE A 77 VAL A 86 ILE A 87 TRP A 90 TYR A 113 ILE A 122 PHE A 130	None	0.58A	6mkeD-1n1aA: 20.7	6mkeD-1n1aA: 43.96

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1BKF_A_FK5A108_1","FK506 BINDING PROTEIN","1n1a","FKBP52","Homo sapiens",8,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;PHE A 130","None","0.65A","1bkfA-1n1aA:17.7","1bkfA-1n1aA:44.96"],["1C9H_A_RAPA108_1","FKBP12.6","1n1a","FKBP52","Homo sapiens",9,"TYR A  57;ASP A  68;PHE A  77;GLU A  85;VAL A  86;ILE A  87;TYR A 113;ILE A 122;PHE A 130","None","0.75A","1c9hA-1n1aA:17.6","1c9hA-1n1aA:38.57"],["1FAP_A_RAPA108_1","FK506-BINDING PROTEIN","1n1a","FKBP52","Homo sapiens",10,"TYR A  57;ASP A  68;PHE A  77;GLU A  85;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.68A","1fapA-1n1aA:18.2","1fapA-1n1aA:45.74"],["1FAP_A_RAPA108_1","FK506-BINDING PROTEIN","1n1a","FKBP52","Homo sapiens",7,"TYR A  57;ASP A  68;PHE A  77;GLU A  85;VAL A  86;TRP A  90;ILE A 122","None","1.11A","1fapA-1n1aA:18.2","1fapA-1n1aA:45.74"],["1FKB_A_RAPA108_1","FK506 BINDING PROTEIN","1n1a","FKBP52","Homo sapiens",9,"TYR A  57;ASP A  68;PHE A  77;GLU A  85;VAL A  86;ILE A  87;TRP A  90;TYR A 113;PHE A 130","None","0.74A","1fkbA-1n1aA:18.2","1fkbA-1n1aA:45.74"],["1FKB_A_RAPA108_1","FK506 BINDING PROTEIN","1n1a","FKBP52","Homo sapiens",7,"TYR A  57;ASP A  68;PHE A  77;GLU A  85;VAL A  86;TRP A  90;ILE A 122","None","1.14A","1fkbA-1n1aA:18.2","1fkbA-1n1aA:45.74"],["1FKF_A_FK5A108_1","FK506 BINDING PROTEIN","1n1a","FKBP52","Homo sapiens",9,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.54A","1fkfA-1n1aA:17.7","1fkfA-1n1aA:45.74"],["1FKJ_A_FK5A108_1","FK506 BINDING PROTEIN","1n1a","FKBP52","Homo sapiens",9,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.54A","1fkjA-1n1aA:17.7","1fkjA-1n1aA:45.74"],["1FKL_A_RAPA108_1","FK506 BINDING PROTEIN","1n1a","FKBP52","Homo sapiens",10,"TYR A  57;ASP A  68;PHE A  77;GLU A  85;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.72A","1fklA-1n1aA:18.2","1fklA-1n1aA:45.74"],["1FKL_A_RAPA108_1","FK506 BINDING PROTEIN","1n1a","FKBP52","Homo sapiens",6,"TYR A  57;ASP A  68;PHE A  77;GLU A  85;VAL A  86;ILE A 122","None","1.00A","1fklA-1n1aA:18.2","1fklA-1n1aA:45.74"],["1PBK_A_RAPA225_1","FKBP25","1n1a","FKBP52","Homo sapiens",9,"TYR A  57;ASP A  68;GLY A  84;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.57A","1pbkA-1n1aA:17.9","1pbkA-1n1aA:39.04"],["1Q6I_A_FK5A301_1","FKBP-TYPE PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKPA","1n1a","FKBP52","Homo sapiens",8,"TYR A  57;ASP A  68;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.65A","1q6iA-1n1aA:15.9","1q6iA-1n1aA:29.52"],["1Q6I_B_FK5B401_1","FKBP-TYPE PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKPA","1n1a","FKBP52","Homo sapiens",8,"TYR A  57;ASP A  68;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.57A","1q6iB-1n1aA:15.7","1q6iB-1n1aA:29.52"],["1R5L_A_VIVA301_0","PROTEIN (ALPHA-TOCOPHEROL TRANSFER PROTEIN)","1n1a","FKBP52","Homo sapiens",5,"ILE A 122;ILE A  25;ILE A 105;VAL A 129;ILE A  87","None","1.18A","1r5lA-1n1aA:undetectable","1r5lA-1n1aA:22.49"],["1TCO_C_FK5C509_2","FK506-BINDING PROTEIN","1n1a","FKBP52","Homo sapiens",9,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.63A","1tcoC-1n1aA:17.8","1tcoC-1n1aA:45.74"],["1YAT_A_FK5A108_1","FK506 BINDING PROTEIN","1n1a","FKBP52","Homo sapiens",9,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.54A","1yatA-1n1aA:19.7","1yatA-1n1aA:39.29"],["2DG3_A_RAPA501_1","FK506-BINDING PROTEIN 1A","1n1a","FKBP52","Homo sapiens",9,"TYR A  57;ASP A  68;PHE A  77;GLU A  85;VAL A  86;ILE A  87;TRP A  90;TYR A 113;PHE A 130","None","0.76A","2dg3A-1n1aA:18.0","2dg3A-1n1aA:45.74"],["2DG3_A_RAPA501_1","FK506-BINDING PROTEIN 1A","1n1a","FKBP52","Homo sapiens",6,"TYR A  57;ASP A  68;PHE A  77;GLU A  85;VAL A  86;ILE A 122","None","1.15A","2dg3A-1n1aA:18.0","2dg3A-1n1aA:45.74"],["2DG4_A_RAPA501_1","FK506-BINDING PROTEIN 1A","1n1a","FKBP52","Homo sapiens",8,"TYR A  57;ASP A  68;PHE A  77;GLU A  85;VAL A  86;ILE A  87;TYR A 113;PHE A 130","None","0.82A","2dg4A-1n1aA:17.6","2dg4A-1n1aA:44.96"],["2DG4_A_RAPA501_1","FK506-BINDING PROTEIN 1A","1n1a","FKBP52","Homo sapiens",6,"TYR A  57;ASP A  68;PHE A  77;GLU A  85;VAL A  86;ILE A 122","None","1.05A","2dg4A-1n1aA:17.6","2dg4A-1n1aA:44.96"],["2DG9_A_RAPA501_1","FK506-BINDING PROTEIN 1A","1n1a","FKBP52","Homo sapiens",7,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A  87;TYR A 113;PHE A 130","None","0.65A","2dg9A-1n1aA:17.8","2dg9A-1n1aA:44.96"],["2DG9_A_RAPA501_1","FK506-BINDING PROTEIN 1A","1n1a","FKBP52","Homo sapiens",5,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A 122","None","1.03A","2dg9A-1n1aA:17.8","2dg9A-1n1aA:44.96"],["2FKE_A_FK5A108_1","FK506 BINDING PROTEIN","1n1a","FKBP52","Homo sapiens",9,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.54A","2fkeA-1n1aA:17.8","2fkeA-1n1aA:45.74"],["2VCD_A_RAPA138_1","OUTER MEMBRANE PROTEIN MIP","1n1a","FKBP52","Homo sapiens",7,"TYR A  57;PHE A  67;ASP A  68;VAL A  86;ILE A  87;TRP A  90;TYR A 113","None","0.83A","2vcdA-1n1aA:14.3","2vcdA-1n1aA:33.56"],["2VN1_A_FK5A501_1","70 KDA PEPTIDYLPROLYL ISOMERASE","1n1a","FKBP52","Homo sapiens",9,"TYR A  57;PHE A  67;ASP A  68;PHE A  77;VAL A  86;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.62A","2vn1A-1n1aA:20.8","2vn1A-1n1aA:39.31"],["2VN1_B_FK5B501_1","70 KDA PEPTIDYLPROLYL ISOMERASE","1n1a","FKBP52","Homo sapiens",8,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;PHE A 130","None","0.67A","2vn1B-1n1aA:20.8","2vn1B-1n1aA:39.31"],["3D4S_A_TIMA401_2","BETA-2 ADRENERGIC RECEPTOR\/T4-LYSOZYME CHIMERA","1n1a","FKBP52","Homo sapiens",3,"THR A  58;SER A  69;PHE A 135","None","0.70A","3d4sA-1n1aA:undetectable","3d4sA-1n1aA:14.58"],["3E4E_A_4PZA501_1","CYTOCHROME P450 2E1","1n1a","FKBP52","Homo sapiens",3,"ALA A  93;THR A  96;CYH A 103","None","0.75A","3e4eA-1n1aA:undetectable","3e4eA-1n1aA:15.15"],["3IHZ_A_FK5A501_1","70 KDA PEPTIDYLPROLYL ISOMERASE, PUTATIVE","1n1a","FKBP52","Homo sapiens",9,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.53A","3ihzA-1n1aA:20.9","3ihzA-1n1aA:39.73"],["3IHZ_A_FK5A501_2","70 KDA PEPTIDYLPROLYL ISOMERASE, PUTATIVE;70 KDA PEPTIDYLPROLYL ISOMERASE, PUTATIVE","1n1a","FKBP52","Homo sapiens",6,"TYR A  57;ASP A  68;PHE A  77;TRP A  90;TYR A 113;ILE A 122","None","0.48A","3ihzB-1n1aA:21.1","3ihzB-1n1aA:39.73"],["3KZ7_A_RAPA225_1","FK506-BINDING PROTEIN 3","1n1a","FKBP52","Homo sapiens",8,"TYR A  57;ASP A  68;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.60A","3kz7A-1n1aA:18.1","3kz7A-1n1aA:45.24"],["3O5R_A_FK5A1001_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","1n1a","FKBP52","Homo sapiens",10,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;LYS A 121;ILE A 122;PHE A 130","None","0.68A","3o5rA-1n1aA:21.5","3o5rA-1n1aA:65.89"],["3UF8_A_FK5A114_1","UBIQUITIN-LIKE PROTEIN SMT3, PEPTIDYL-PROLYL CIS-TRANS ISOMERASE","1n1a","FKBP52","Homo sapiens",9,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.57A","3uf8A-1n1aA:19.0","3uf8A-1n1aA:35.24"],["3UQA_A_FK5A114_1","UBIQUITIN-LIKE PROTEIN SMT3, PEPTIDYL-PROLYL CIS-TRANS ISOMERASE","1n1a","FKBP52","Homo sapiens",9,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.59A","3uqaA-1n1aA:18.8","3uqaA-1n1aA:35.24"],["3UQB_A_FK5A114_1","UBIQUITIN-LIKE PROTEIN SMT3, PEPTIDYL-PROLYL CIS-TRANS ISOMERASE","1n1a","FKBP52","Homo sapiens",8,"TYR A  57;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.54A","3uqbA-1n1aA:19.1","3uqbA-1n1aA:34.76"],["3VAW_A_FK5A114_1","UBIQUITIN-LIKE PROTEIN SMT3,PEPTIDYL-PROLYL CIS-TRANS ISOMERASE","1n1a","FKBP52","Homo sapiens",9,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.58A","3vawA-1n1aA:18.4","3vawA-1n1aA:35.24"],["4DRH_A_RAPA201_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","1n1a","FKBP52","Homo sapiens",9,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.68A","4drhA-1n1aA:20.7","4drhA-1n1aA:61.43"],["4DRH_A_RAPA201_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","1n1a","FKBP52","Homo sapiens",5,"TYR A  57;ASP A  68;TYR A 113;LYS A 121;ILE A 122","None","0.87A","4drhA-1n1aA:20.7","4drhA-1n1aA:61.43"],["4DRH_D_RAPD201_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","1n1a","FKBP52","Homo sapiens",9,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.64A","4drhD-1n1aA:20.8","4drhD-1n1aA:61.43"],["4DRI_A_RAPA201_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","1n1a","FKBP52","Homo sapiens",9,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.56A","4driA-1n1aA:22.5","4driA-1n1aA:61.43"],["4DRJ_A_RAPA201_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP4","1n1a","FKBP52","Homo sapiens",10,"TYR A  57;ASP A  68;PHE A  77;GLU A  85;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.59A","4drjA-1n1aA:22.6","4drjA-1n1aA:100.00"],["4DZ2_A_FK5A200_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE;PEPTIDYL-PROLYL CIS-TRANS ISOMERASE","1n1a","FKBP52","Homo sapiens",9,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.56A","4dz2A-1n1aA:18.8;4dz2B-1n1aA:18.9","4dz2A-1n1aA:47.45;4dz2B-1n1aA:47.45"],["4DZ2_B_FK5B200_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE;PEPTIDYL-PROLYL CIS-TRANS ISOMERASE","1n1a","FKBP52","Homo sapiens",9,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.55A","4dz2A-1n1aA:18.8;4dz2B-1n1aA:18.9","4dz2A-1n1aA:47.45;4dz2B-1n1aA:47.45"],["4DZ3_A_FK5A201_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE","1n1a","FKBP52","Homo sapiens",9,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.55A","4dz3A-1n1aA:18.9","4dz3A-1n1aA:47.45"],["4DZ3_B_FK5B201_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE","1n1a","FKBP52","Homo sapiens",9,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.57A","4dz3B-1n1aA:13.6","4dz3B-1n1aA:47.45"],["4LAX_A_FK5A301_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP4","1n1a","FKBP52","Homo sapiens",10,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;LYS A 121;ILE A 122;PHE A 130","None","0.58A","4laxA-1n1aA:22.1","4laxA-1n1aA:86.58"],["4NNR_A_FK5A201_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP2;PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP2","1n1a","FKBP52","Homo sapiens",6,"ASP A  68;PHE A  77;TRP A  90;TYR A 113;LYS A 121;ILE A 122","None","0.76A","4nnrA-1n1aA:15.0;4nnrB-1n1aA:15.0","4nnrA-1n1aA:41.67;4nnrB-1n1aA:41.67"],["4NNR_A_FK5A201_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP2;PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP2","1n1a","FKBP52","Homo sapiens",9,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.56A","4nnrA-1n1aA:15.0;4nnrB-1n1aA:15.0","4nnrA-1n1aA:41.67;4nnrB-1n1aA:41.67"],["4NNR_B_FK5B201_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP2","1n1a","FKBP52","Homo sapiens",10,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;LYS A 121;ILE A 122;PHE A 130","None","0.70A","4nnrB-1n1aA:15.0","4nnrB-1n1aA:41.67"],["4ODO_A_FK5A205_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE SLYD","1n1a","FKBP52","Homo sapiens",5,"TYR A  57;ASP A  68;ILE A  87;TYR A 113;PHE A 130","None","0.68A","4odoA-1n1aA:11.4","4odoA-1n1aA:18.24"],["4ODO_B_FK5B203_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE SLYD","1n1a","FKBP52","Homo sapiens",5,"TYR A  57;ASP A  68;ILE A  87;TYR A 113;PHE A 130","None","0.65A","4odoB-1n1aA:11.1","4odoB-1n1aA:18.24"],["4ODO_C_FK5C204_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE SLYD","1n1a","FKBP52","Homo sapiens",5,"TYR A  57;ASP A  68;ILE A  87;TYR A 113;PHE A 130","None","0.67A","4odoC-1n1aA:11.0","4odoC-1n1aA:18.24"],["4ODR_A_FK5A201_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE SLYD, PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP1A CHIMERA;PEPTIDYL-PROLYL CIS-TRANS ISOMERASE SLYD, PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP1A CHIMERA","1n1a","FKBP52","Homo sapiens",6,"TYR A  57;ASP A  68;ILE A  87;TYR A 113;ILE A 122;PHE A 130","None","0.61A","4odrA-1n1aA:12.9;4odrB-1n1aA:13.0","4odrA-1n1aA:25.17;4odrB-1n1aA:25.17"],["4ODR_B_FK5B201_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE SLYD, PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP1A CHIMERA;PEPTIDYL-PROLYL CIS-TRANS ISOMERASE SLYD, PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP1A CHIMERA","1n1a","FKBP52","Homo sapiens",5,"TYR A  57;ASP A  68;ILE A  87;TYR A 113;PHE A 130","None","0.66A","4odrA-1n1aA:12.9;4odrB-1n1aA:13.0","4odrA-1n1aA:25.17;4odrB-1n1aA:25.17"],["4QT2_A_RAPA202_1","FK506-BINDING PROTEIN (FKBP)-TYPE PEPTIDYL-PROPYL ISOMERASE","1n1a","FKBP52","Homo sapiens",10,"TYR A  57;ASP A  68;PHE A  77;GLU A  85;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.69A","4qt2A-1n1aA:20.9","4qt2A-1n1aA:36.81"],["4QT3_A_RAPA202_1","FK506-BINDING PROTEIN (FKBP)-TYPE PEPTIDYL-PROPYL ISOMERASE","1n1a","FKBP52","Homo sapiens",10,"TYR A  57;ASP A  68;PHE A  77;GLU A  85;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.70A","4qt3A-1n1aA:20.3","4qt3A-1n1aA:38.19"],["5B8I_C_FK5C201_3","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE","1n1a","FKBP52","Homo sapiens",9,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.63A","5b8iC-1n1aA:17.5","5b8iC-1n1aA:37.09"],["5D75_A_FK5A301_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP3","1n1a","FKBP52","Homo sapiens",8,"TYR A  57;ASP A  68;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.53A","5d75A-1n1aA:18.7","5d75A-1n1aA:39.19"],["5ESL_A_1YNA701_2","LANOSTEROL 14-ALPHA DEMETHYLASE","1n1a","FKBP52","Homo sapiens",4,"ALA A 116;PRO A 109;GLY A  22;LEU A  62","None","0.98A","5eslA-1n1aA:undetectable","5eslA-1n1aA:12.97"],["5GPG_A_RAPA301_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP3","1n1a","FKBP52","Homo sapiens",8,"TYR A  57;ASP A  68;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.59A","5gpgA-1n1aA:18.6","5gpgA-1n1aA:47.11"],["5HKG_A_RAPA201_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP1B","1n1a","FKBP52","Homo sapiens",9,"TYR A  57;ASP A  68;PHE A  77;GLU A  85;VAL A  86;ILE A  87;TYR A 113;ILE A 122;PHE A 130","None","0.76A","5hkgA-1n1aA:17.7","5hkgA-1n1aA:38.57"],["5HUA_A_FK5A201_1","FK506-BINDING PROTEIN 1","1n1a","FKBP52","Homo sapiens",8,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;PHE A 130","None","0.52A","5huaA-1n1aA:20.0","5huaA-1n1aA:41.84"],["5HW8_A_FK5A201_1","FK506-BINDING PROTEIN 1;FK506-BINDING PROTEIN 1","1n1a","FKBP52","Homo sapiens",8,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122","None","0.65A","5hw8A-1n1aA:16.5;5hw8D-1n1aA:16.7","5hw8A-1n1aA:36.49;5hw8D-1n1aA:36.49"],["5HW8_B_FK5B201_1","FK506-BINDING PROTEIN 1","1n1a","FKBP52","Homo sapiens",5,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A 122","None","1.22A","5hw8B-1n1aA:16.5","5hw8B-1n1aA:36.49"],["5HW8_B_FK5B201_1","FK506-BINDING PROTEIN 1","1n1a","FKBP52","Homo sapiens",8,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.52A","5hw8B-1n1aA:16.5","5hw8B-1n1aA:36.49"],["5HW8_C_FK5C201_1","FK506-BINDING PROTEIN 1;FK506-BINDING PROTEIN 1","1n1a","FKBP52","Homo sapiens",8,"TYR A  57;ASP A  68;VAL A  86;ILE A  87;TRP A  90;TYR A 113;LEU A 128;PHE A 130","None","0.59A","5hw8C-1n1aA:16.4;5hw8H-1n1aA:13.5","5hw8C-1n1aA:36.49;5hw8H-1n1aA:36.49"],["5HW8_D_FK5D201_1","FK506-BINDING PROTEIN 1","1n1a","FKBP52","Homo sapiens",9,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.59A","5hw8D-1n1aA:16.7","5hw8D-1n1aA:36.49"],["5HW8_E_FK5E201_1","FK506-BINDING PROTEIN 1","1n1a","FKBP52","Homo sapiens",8,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;PHE A 130","None","0.69A","5hw8E-1n1aA:16.6","5hw8E-1n1aA:36.49"],["5HW8_F_FK5F201_1","FK506-BINDING PROTEIN 1;FK506-BINDING PROTEIN 1;FK506-BINDING PROTEIN 1","1n1a","FKBP52","Homo sapiens",8,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;PHE A 130","None","0.61A","5hw8B-1n1aA:16.5;5hw8F-1n1aA:13.5;5hw8G-1n1aA:16.6","5hw8B-1n1aA:36.49;5hw8F-1n1aA:36.49;5hw8G-1n1aA:36.49"],["5HW8_G_FK5G201_2","FK506-BINDING PROTEIN 1","1n1a","FKBP52","Homo sapiens",9,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.62A","5hw8G-1n1aA:16.6","5hw8G-1n1aA:36.49"],["5HW8_H_FK5H201_1","FK506-BINDING PROTEIN 1","1n1a","FKBP52","Homo sapiens",5,"ASP A  68;PHE A  77;VAL A  86;ILE A  87;TRP A  90","None","0.55A","5hw8H-1n1aA:13.5","5hw8H-1n1aA:36.49"],["5HW8_H_FK5H201_1","FK506-BINDING PROTEIN 1","1n1a","FKBP52","Homo sapiens",6,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;TRP A  90;PHE A 130","None","0.59A","5hw8H-1n1aA:13.5","5hw8H-1n1aA:36.49"],["5HWC_A_FK5A201_1","FK506-BINDING PROTEIN 1A","1n1a","FKBP52","Homo sapiens",9,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.52A","5hwcA-1n1aA:18.1","5hwcA-1n1aA:42.75"],["6MKE_A_FK5A201_0","PEPTIDYLPROLYL ISOMERASE","1n1a","FKBP52","Homo sapiens",9,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.56A","6mkeA-1n1aA:20.8;6mkeD-1n1aA:20.7","6mkeA-1n1aA:43.96;6mkeD-1n1aA:43.96"],["6MKE_B_FK5B201_0","PEPTIDYLPROLYL ISOMERASE","1n1a","FKBP52","Homo sapiens",9,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.52A","6mkeB-1n1aA:20.8;6mkeC-1n1aA:20.7","6mkeB-1n1aA:43.96;6mkeC-1n1aA:43.96"],["6MKE_C_FK5C201_1","PEPTIDYLPROLYL ISOMERASE","1n1a","FKBP52","Homo sapiens",9,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.59A","6mkeC-1n1aA:20.7","6mkeC-1n1aA:43.96"],["6MKE_D_FK5D201_1","PEPTIDYLPROLYL ISOMERASE","1n1a","FKBP52","Homo sapiens",9,"TYR A  57;ASP A  68;PHE A  77;VAL A  86;ILE A  87;TRP A  90;TYR A 113;ILE A 122;PHE A 130","None","0.58A","6mkeD-1n1aA:20.7","6mkeD-1n1aA:43.96"]]